reports
- Claire Wang Kelai
- Damon Shen
- Greater China Research Team
- Jieqi Liu
- Julia Pan Mengyao
- Ming San Soong
- Tham Mun Hon
Greater China Daily: Tuesday, December 9, 2025
Top Stories Economics | Trade Exports growth rebounded to 5.9% yoy in November, beating consensus estimates, driven by a recovery in EU and Japan shipments, although exports to the US weakened further. Imports rose 1.9% yoy, below consensus expectations, amid mixed commodity performances. The trade surplus widened to US$111.7b. Exports of motor vehicle, hi-tech and mechanical & electrical goods improved, while integrated circuit imports strengthened. Overall, trade data showed resilience via di...
Moody's Ratings announces completion of a periodic review of ratings o...
Moody's Ratings (Moody's) has completed a periodic review of the ratings of Novartis AG and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 1 December 2025 in which we reassessed the appropriateness of the ratings in the context of the...
Netcapital Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5...
Netcapital Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) BOSTON, MA, Dec. 08, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: NCPL, NCPLW) (the “Company”), a digital private capital markets ecosystem, announced today the grant of an inducement restricted stock award of 1,000,000 shares of common stock (“Restricted Stock Award”) to a new employee under the Netcapital Inc. 2023 Omnibus Equity Incentive Plan (the “Plan”). The Restricted Stock Award was granted as an inducement under the Plan and related form of restricted stock award agreement in accordance with Nasdaq Listing Rule...
- Heidi Mo Jinghui
- Kai Jie Tang
Singapore Daily: Tuesday, December 9, 2025
Top Stories Company Results | LHN (LHN SP/BUY/S$0.675/Target: S$0.84) LHN delivered FY25 core PATMI of S$34.5m (+24% yoy), in line with expectations. The group declared a final and special dividend of 1 and 2 S cents respectively, bringing total dividend to 4 S cents, with a 48.8% payout and 4.3% yield. LHN trades at 10.0x adjusted FY26F PE, a 40% discount to peers. Maintain BUY with a lower target price of S$0.84. Market Spotlight • US stocks were lower on Monday, with all three indexes slidin...
- Heidi Mo Jinghui
- Kai Jie Tang
LHN (LHN SP) - FY25: Results In Line; Building Momentum Beyond Coliwoo...
LHN delivered FY25 core PATMI of S$34.5m (+24% yoy), in line with expectations. The group declared a final and special dividend of 1 and 2 S cents respectively, bringing total dividend to 4 S cents, with a 48.8% payout and 4.3% yield. LHN trades at 10.0x adjusted FY26F PE, a 40% discount to peers. Maintain BUY with a lower target price of S$0.84.
Moody's Ratings corrects website display for two CUSIPs of Robbinsvill...
Moody's Ratings (Moody's) has corrected the display on its websites for Robbinsville Public School District, NJ's Refunding School Bonds, Series 2005, CUSIPs 940456ET9 and 940456EU6. The rating history for these bonds has been updated to reflect the affirmation of the Aa3 underlying rating on April ...
Monument Mining Announces Results of Annual General Meeting of Shareho...
Monument Mining Announces Results of Annual General Meeting of Shareholders VANCOUVER, British Columbia, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Monument Mining Limited (TSX-V: MMY and FSE: D7Q1) (“Monument” or the “Company”) is pleased to announce the results from its Annual General Meeting of shareholders (the “AGM”) held on December 08, 2025, in Vancouver, B.C. The Company has received record high participation for the AGM with 43.23% of shares voted. Resolutions tabled as proposed in the Information Circular dated on October 27, 2025 were all passed, and more than 95% “For” for each, inclu...
Moody's Ratings assigns Aa3 to Corona-Norco USD, CA's GOs; outlook pos...
Moody's Ratings (Moody's) has assigned a Aa3 rating to Corona-Norco Unified School District, CA's proposed $90.6 million Election of 2014 General Obligation Bonds, Series D. We maintain an A1 issuer rating and Aa3 ratings on the district's outstanding general obligation unlimited tax (GOULT) bonds. ...
- Willinoy Sitorus
Strategy - KTA From 1H26 Strategy Conference In Kuala Lumpur
Strategy | KTA From 1H26 Strategy Conference In Kuala Lumpur We conducted a marketing trip to Kuala Lumpur and met with more than 20 investors to present our 1H26 strategy. Among our four key themes, the strongest interest centred on the copper-related narrative, with many investors also asking if this is the right time to re-enter the banking and consumer sectors. Highlights • Interest largely centred on the copper-related theme. • Attractive risk-reward in selected large caps, with dividend y...
BBCA PT BANK CENTRAL ASIA TBK
TLKM PT TELKOM INDONESIA (PERSERO) TBK CLASS B
HEAL MEDIKALOKA HERMINA
CMRY PT CISARUA MOUNTAIN DAIRY TBK
MDKA MERDEKA COPPER GOLD TBK PT
BRMS IJ BUMI RESOURCES MINERALS
DEWA IJ DARMA HENWA (DEWA IJ)
ASSA IJ ADI SARANA ARMADA TBK PT (ASSA IJ)
ARCI IJ ARCHI INDONESIA (ARCI IJ)
Moody's Ratings affirms Antero Midstream's Ba1 CFR; stable outlook
Moody's Ratings (Moody's) affirmed Antero Midstream Partners LP's (AM) Ba1 Corporate Family Rating (CFR), Ba1-PD Probability of Default Rating (PDR), and its Ba2 backed senior unsecured notes rating. The SGL-2 Speculative Grade Liquidity Rating (SGL) remains unchanged. The outlook is stable. The a...
Moody's Ratings upgrades Children's Hospital Colorado to Aa3; outlook ...
Moody's Ratings (Moody's) has upgraded Children's Hospital Colorado's (CHCO) revenue bond rating to Aa3 from A1. The outlook was revised to stable from positive. CHCO has approximately $680 million of debt outstanding. The upgrade to Aa3 is driven by CHCO's significant operating improvements, stro...
Moody's Ratings changes Antero Resources' outlook to stable on acquisi...
Moody's Ratings (Moody's) changed Antero Resources Corporation's (AR) rating outlook to stable from positive and concurrently affirmed the company's Ba1 Corporate Family Rating (CFR), Ba1-PD Probability of Default Rating (PDR) and Ba1 senior unsecured notes rating. AR's SGL-1 Speculative Grade Liqui...
Brookfield Corporation Announces Pricing of C$1 Billion of Medium-Term...
Brookfield Corporation Announces Pricing of C$1 Billion of Medium-Term Notes NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION TO THE UNITED STATES BROOKFIELD, NEWS, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Brookfield Corporation (NYSE: BN, TSX: BN) today announced the pricing of a public offering of C$1 billion aggregate principal amount of medium-term notes (“notes”), comprised of C$350 million aggregate principal amount of medium term notes due March 1, 2033, which will bear interest at a rate of 4.388% per annum, payable semi-annually and C$650 million aggregate principal ...
ASH 2025 | Ascentage Pharma Presents First Dataset from Phase III POLA...
ASH 2025 | Ascentage Pharma Presents First Dataset from Phase III POLARIS-1 Study of Olverembatinib in Newly Diagnosed Ph+ ALL Shows a Best MRD-Negativity CR Rate Exceeding 60% By the end of 3 induction cycles, the best minimal residual disease (MRD) negativity rate and the MRD-negative complete response (CR) rate were 66.0% and 64.2%, respectivelyHigh-risk IKZF1plus patients showed 90% molecular response rate Low-intensity chemotherapy combination achieved deep responses with favorable safety profile ROCKVILLE, Md. and SUZHOU, China, Dec. 08, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: AAPG; HKEX...
ASH 2025 | Ascentage Pharma Presents Four-Year Follow-Up Data from Reg...
ASH 2025 | Ascentage Pharma Presents Four-Year Follow-Up Data from Registrational Phase II Study of Olverembatinib, Reaffirming Differentiated Long-Term Efficacy and Safety in TKI-Resistant/Intolerant CML-CP Dramatically improved disease control with 21.2 months vs. 2.9 months median event-free survival (EFS) Favorable safety profile with 7% vascular occlusion rate Broad patient benefit with proven effectiveness even in patients without T315I mutation (11.9 vs. 3.1 months event-free survival) ROCKVILLE, Md. and SUZHOU, China, Dec. 08, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: AAPG; HKEX: 6855...
ASH 2025 | Updated Data for Ascentage Pharma‘s Olverembatinib in Secon...
ASH 2025 | Updated Data for Ascentage Pharma‘s Olverembatinib in Second-Line CML-CP Showing Encouraging Potential for Early-Line Treatment 76.7% complete cytogenetic response rate achieved in patients who failed second-generation TKI first-line therapy Molecular responses continue to deepen with extended treatment duration, reaching 60% major molecular response at 21 cyclesStrong efficacy data support potential advancement to earlier treatment lines for a broader patient population ROCKVILLE, Md. and SUZHOU, China, Dec. 08, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: AAPG; HKEX: 6855), a global, c...
- Maskun Ramli
- Willinoy Sitorus
Indonesia Daily - Tuesday, December 9, 2025
Strategy | KTA From 1H26 Strategy Conference In Kuala Lumpur We conducted a marketing trip to Kuala Lumpur and met with more than 20 investors to present our 1H26 strategy. Among our four key themes, the strongest interest centred on the copper-related narrative, with many investors also asking if this is the right time to re-enter the banking and consumer sectors. Technical Analysis Sumber Alfaria Trijaya | AMRT IJ Trading Buy Range: We have a technical Buy at Rp1,920, and take profit at Rp2,0...
BBCA PT BANK CENTRAL ASIA TBK
TLKM PT TELKOM INDONESIA (PERSERO) TBK CLASS B
HEAL MEDIKALOKA HERMINA
CMRY PT CISARUA MOUNTAIN DAIRY TBK
MDKA MERDEKA COPPER GOLD TBK PT
BRMS IJ BUMI RESOURCES MINERALS
DEWA IJ DARMA HENWA (DEWA IJ)
ASSA IJ ADI SARANA ARMADA TBK PT (ASSA IJ)
ARCI IJ ARCHI INDONESIA (ARCI IJ)
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.